U S Physical Therapy (USPH) EBITDA (2010 - 2026)

U S Physical Therapy (USPH) has 17 years of EBITDA data on file, last reported at $12.5 million in Q1 2026.

• Quarterly EBITDA fell 36.46% year-over-year to $12.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $79.5 million (up 17.44% YoY) and the FY2025 annual result came in at $86.7 million, up 37.6% from the prior year.
• EBITDA slipped to $12.5 million in Q1 2026 per USPH's latest filing, from $16.8 million in the prior quarter.
• The five-year high for EBITDA was $25.3 million in Q3 2025, with the low at -$40.7 million in Q4 2022.
• Average EBITDA over 5 years is $13.1 million, with a median of $15.9 million recorded in 2023.
• Year-over-year, EBITDA slumped 347.19% in 2022 and jumped 908.68% in 2024.
• U S Physical Therapy's EBITDA stood at -$40.7 million in 2022, then soared by 94.03% to -$2.4 million in 2023, then jumped by 908.68% to $19.7 million in 2024, then fell by 14.68% to $16.8 million in 2025, then retreated by 25.56% to $12.5 million in 2026.
• Business Quant data shows USPH's EBITDA at $12.5 million in Q1 2026, $16.8 million in Q4 2025, and $25.3 million in Q3 2025.